{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T10:46:20Z","timestamp":1649155580027},"reference-count":16,"publisher":"Japanese Society of Internal Medicine","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,8,15]]},"DOI":"10.2169\/internalmedicine.6780-20","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T22:06:23Z","timestamp":1615154783000},"page":"2687-2691","source":"Crossref","is-referenced-by-count":1,"title":["Eribulin Mesylate-related Multifocal Demyelinating Neuropathy with Myokymia in a Breast Cancer Patient"],"prefix":"10.2169","volume":"60","author":[{"given":"Marie","family":"Tsunogae","sequence":"first","affiliation":[{"name":"Department of Neurology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuma","family":"Shiomi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Kikawa","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Kohara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michi","family":"Kawamoto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Cortes J, O'Shaughnessy J, Loesch D, et al. Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study. Lancet 377: 914-923, 2011.","DOI":"10.1016\/S0140-6736(11)60070-6"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Zhao B, Zhao H, Zhao J. Incidence and clinical parameters associated with eribulin mesylate-induced peripheral neuropathy. Crit Rev Oncol Hematol 128: 110-117, 2018.","DOI":"10.1016\/j.critrevonc.2018.06.003"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Komlodi-Pasztor E, Sackett D, Wilkerson J, Fojo T. Mitosis is not a key target of microtubule agents in patient tumors. Nat Rev Clin Oncol 8: 244-250, 2011.","DOI":"10.1038\/nrclinonc.2010.228"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Malik B, Stillman M. Chemotherapy-induced peripheral neuropathy. Curr Neurol Neurosci Rep 8: 56-65, 2008.","DOI":"10.1007\/s11910-008-0010-5"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Han Y, Smith MT. Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN). Front Pharmacol 4: 156, 2013.","DOI":"10.3389\/fphar.2013.00156"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Peyronnard C, Charpentier D, Botez SA. A case of eribulin mesylate and demyelinating polyneuropathy with myokymic discharges. Muscle Nerve 53: 151-152, 2016.","DOI":"10.1002\/mus.24890"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kuwabara S, Misawa S. Chronic inflammatory demyelinating polyneuropathy. Adv Exp Med Biol 1190: 333-343, 2019.","DOI":"10.1007\/978-981-32-9636-7_21"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kuwabara S, Isose S, Mori M, et al. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 86: 1054-1059, 2015.","DOI":"10.1136\/jnnp-2014-308452"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kuttiappan G, Sivakumar S, Thiruvarutchelvan K. Limb myokymia in Guillan-Barr\u00e9 syndrome. Neurol India 68: 230-233, 2020.","DOI":"10.4103\/0028-3886.279682"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Mateer JE, Gutmann L, McComas CF. Myokymia in Guillan-Barr\u00e9 syndrome. Neurology 33: 374-376, 1983.","DOI":"10.1212\/WNL.33.3.374"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Chhibber S, Greenberg SA. Teaching video neuroimages: widespread clinical myokymia in chronic inflammatory demyelinating polyneuropathy. Neurology 77: e33, 2011.","DOI":"10.1212\/WNL.0b013e318227b202"},{"key":"12","unstructured":"12. Basiri K, Fatehi F, Chitsaz A. Isaac's syndrome associated with CIDP and pregnancy. Arch Iran Med 14: 206-208, 2011."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Yeh WZ, Dyck PJ, van den Berg LH, Kiernan MC, Taylor BV. Multifocal motor neuropathy: controversies and priorities. J Neurol Neurosurg Psychiatry 91: 140-148, 2020.","DOI":"10.1136\/jnnp-2019-321532"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Roth G, Magistris MR. Neuropathies with prolonged conduction block, single and grouped fasciculations, localized limb myokymia. Electroencephalogr Clin Neurophysiol 67: 428-438, 1987.","DOI":"10.1016\/0013-4694(87)90006-X"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kiernan MC, Guglielmi JM, Kaji R, Murray NM, Bostock H. Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block. Brain 125: 664-675, 2002.","DOI":"10.1093\/brain\/awf041"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Roth G, Rohr J, Magistris MR, Ochsner F. Motor neuropathy with proximal multifocal persistent conduction block, fasciculations and myokymia. Evolution to tetraplegia. Eur Neurol 25: 416-423, 1986.","DOI":"10.1159\/000116045"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/16\/60_6780-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T03:44:56Z","timestamp":1629517496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/16\/60_6780-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,15]]},"references-count":16,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6780-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,15]]},"article-number":"6780-20"}}